Oncology & Cancer

Having HIV and chronic HBV/HCV coinfection may increase cancer risk

In HIV-infected patients receiving antiretroviral therapy (ART), chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is associated with an increased risk for non-Hodgkin's lymphoma. The findings are published ...

Diseases, Conditions, Syndromes

Newer tests could cut hep C diagnosis steps in half

Data suggest that several commercially available tests for hepatitis C virus core antigen (HCVcAg) are highly sensitive and specific and could transform the current two-test screening process for HCV into a single test. A ...

Diseases, Conditions, Syndromes

New test allows for one-step diagnosis of HCV infection

The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. Now researchers ...

Diseases, Conditions, Syndromes

Rare disease gene has a key role in chronic hepatitis C infection

Hepatitis C virus (HCV) hijacks the host's fat metabolism for its own survival, growth, and transport in the human body. A study published on April 28th in PLOS Pathogens identifies a host gene involved in the formation of ...

Diseases, Conditions, Syndromes

Hepatitis C virus uses Netrin-1 to hijack host cells

Hepatitis C virus (HCV) is a small, enveloped virus comprising an RNA genome encased in a protein capsid and surrounded by a lipid bilayer containing two glycoproteins. Acute infection can cause hepatitis but the virus usually ...

Diseases, Conditions, Syndromes

Total medical costs of $16K for IFN-based antiviral tx for HCV

(HealthDay)—The total medical costs associated with interferon (IFN)-based antiviral treatment among patients with chronic hepatitis C virus (HCV) infection average €14,559, with a mean cost of €38,514 per sustained ...

page 4 from 7